MedTrace Logo

Composite Variability Index and Propofol Remifentanil Anesthesia

NCT01234194 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2010-11-04

No results posted yet for this study

Summary

The purpose of the study is to determine if the new Composite Variability Index (CVI) is capable of detecting changing effect compartment concentrations of remifentanil. In addition, it is planed to detect if the change in CVI in response to a standardized painful stimulus is dose-dependent.

Conditions

  • Measure of Nociception

Interventions

DRUG

rising remifentanil concentrations

remifentanil effect-compartment concentrations 0,1,2,3 ng/ml

DRUG

falling remifentanil concentrations

remifentanil effect-compartment concentrations 3, 2, 1, 0 ng/ml

Sponsors & Collaborators

  • University Hospital, Bonn

    lead OTHER

Principal Investigators

  • Richard K Ellerkmann, M.D. · University of Bonn

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-11-30
Primary Completion
2010-07-31
Completion
2010-07-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01234194 on ClinicalTrials.gov